Skip to content
PICO Portalanswers from OpenAlex

Colchicine Attenuates Inflammation Beyond the Inflammasome in Chronic Coronary Artery Disease

PaperCitations, authors & open-access status

Colchicine Attenuates Inflammation Beyond the Inflammasome in Chronic Coronary Artery Disease is a paper indexed in PICO Portal from OpenAlex.

How many citations does Colchicine Attenuates Inflammation Beyond the Inflammasome in Chronic Coronary Artery Disease have?

PICO Portalcitation count

Colchicine Attenuates Inflammation Beyond the Inflammasome in Chronic Coronary Artery Disease has 147 citations in the OpenAlex counts PICO Portal stores.

When was Colchicine Attenuates Inflammation Beyond the Inflammasome in Chronic Coronary Artery Disease published?

PICO Portalyear

Colchicine Attenuates Inflammation Beyond the Inflammasome in Chronic Coronary Artery Disease has 2020 year in the PICO Portal index.

What is the open-access status of Colchicine Attenuates Inflammation Beyond the Inflammasome in Chronic Coronary Artery Disease?

PICO Portaloa status

Colchicine Attenuates Inflammation Beyond the Inflammasome in Chronic Coronary Artery Disease has bronze oa status in the PICO Portal index.

What is the DOI of Colchicine Attenuates Inflammation Beyond the Inflammasome in Chronic Coronary Artery Disease?

PICO Portaldoi

The DOI for Colchicine Attenuates Inflammation Beyond the Inflammasome in Chronic Coronary Artery Disease is on the source record.

What is the PMID of Colchicine Attenuates Inflammation Beyond the Inflammasome in Chronic Coronary Artery Disease?

PICO Portalpmid

The PMID for Colchicine Attenuates Inflammation Beyond the Inflammasome in Chronic Coronary Artery Disease is on the source record.

What is the OpenAlex record for Colchicine Attenuates Inflammation Beyond the Inflammasome in Chronic Coronary Artery Disease?

PICO Portalopenalex

The OpenAlex for Colchicine Attenuates Inflammation Beyond the Inflammasome in Chronic Coronary Artery Disease is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial